My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
Requested Re-print of BMJ 2012;345:e8462  - Original PDF File: Pharma Crime Pays Corporate crime in the pharmaceutical industry is common, serious and repetitive by Peter C. Gøtzsche, Professor MD, DrMedSci, MSc Nordic Cochrane…
Study examines FDA influence on design of pivotal drug studies An examination of the potential interaction between pharmaceutical companies and the U.S. Food and Drug Administration (FDA) to discuss future…
Public release date: 9-Aug-2011 Press release from PLoS Medicine Rather than ensure the proper attribution of authorship, rules set up by leading medical journals to define and credit authorship of…
The potential conflict of interest for leaders of AMCs serving on pharmaceutical boards  About 40 percent of pharmaceutical company boards of directors examined had at least one member who…
Public release date: 19-Oct-2010 - [caption id="" align="aligncenter" width="320"] Money cash (Photo credit: @Doug88888)[/caption] TORONTO, October 19, 2010 – Pharmaceutical promotion may cause doctors to prescribe more expensively, less appropriately…
Public release date: 30-Sep-2010 ‘Sex, Lies and Pharmaceuticals’ [caption id="" align="aligncenter" width="300"] Fukitol - 1000mg ... How I Accidentally Became a Drug Dealer (Wed., Nov. 27 2013) ...item 2.. T.P.D.…
Public release date: 17-Aug-2010 - they spend two to three times more on marketing than on research to persuade doctors to prescribe these new drugs- Doctors may get misleading information…
- You have written about the possibility of using "anti-love biotechnology" as a treatment. When would it be warranted? [caption id="" align="aligncenter" width="350"] English: Broken heart sewn back together (Photo…
Taking a cue from Apple and Coca-Cola, pharmaceutical firms are humanizing their brands Version française Montreal, February 4, 2014 — By 2018, it is estimated that the…
Public release date: 18-Mar-2010 - Virtually all (94%) of the scientific authors who provided positive results for the anti-diabetic drug rosiglitazone had financial relationships with pharmaceutical companies, Research: Association between…
Contact: Stephanie Burns sburns@bmj.com 44-020-738-36529 BMJ-British Medical Journal Competing interests should be declared -- and reported -- to maintain credibility of public health, say researchersAcademics with links to the pharmaceutical industry…
Article by: Peter Whoriskey Washington Post October 6, 2013 - 11:15 PM WASHINGTON – A scientific panel that shaped the federal government’s policy for testing the safety and effectiveness…
Taxpayers are being charged up to 40 times the usual cost for common over-the-counter products being prescribed by NHS doctors, The Telegraph can disclose. The NHS confirmed that inflated prices…
Drug companies exploit loophole in the law to hike prices by as much as 2,000 per cent Sanchez Manning Sunday, 14 July 2013 Drugs companies have been accused of “highway…
Contact: Kathy Fackelmann kfackelmann@gwu.edu 202-994-8354 George Washington University School of Public Health and Health Services Conflict-of-interest restrictions needed to ensure strong FDA review Panel members with ties to industry might…
Several patients died in tests made possible by massive payoffs to Communist regime Tony Paterson Sunday, 12 May 2013 Leading Western pharmaceutical companies paid millions of pounds to former Communist…
Published time: February 28, 2013 01:36Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â AFP Photo / Louisa Gouliamaki The Greek government has reportedly accused 50 leading pharmaceutical companies of cutting off supplies of key medications to…
"The mechanism set up by PhRMA for consumers to make complaints does not function: the FAX machine is typically not connected and complaints go unanswered." Contact: Buffie Stephens buffiestephens@uncc.edu…
By Stephen Curry, The Guardian Monday, December 24, 2012 11:11 EST Topics: clinical trials You should read it because behind the anodyne cover lurks a tale of horrific fascination…
2010 report posted for filing Contact: Daniel Fowler fowler@asanet.org 202-527-7885 American Sociological Association Incentives and protections for industry encourage development of many drugs with few new benefits over existing pharmaceuticals,…
You must be logged in to post a comment.